Datar gets FDA breakthrough status for blood test to detect prostate cancer
The TriNetra-Prostate is a circulating tumour cell detection blood test that identifies early-stage prostate cancer in men aged…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
15 Feb 22
The TriNetra-Prostate is a circulating tumour cell detection blood test that identifies early-stage prostate cancer in men aged…
14 Feb 22
According to pseudovirus and authentic virus data, bebtelovimab has shown neutralisation activity against widely circulating variant of concern,…
11 Feb 22
The US drugmaker has used several insights from the CytoReason’ platform, in several of its R&D programmes across…
11 Feb 22
The investigational Covid-19 drug, bebtelovimab, has shown to maintain binding and neutralising activity across currently known and reported…
10 Feb 22
When it comes to the benefits of probiotics, there is much to discover. We speak to consultant Dr…
10 Feb 22
The investment round, jointly led by SoftBank Vision Fund 2 and RA Capital Management, will advance the company’s…
10 Feb 22
Gentis offers specialised DNA testing services, including obstetrical genetics, genealogical DNA tests, oncology, and Covid-19 testing services
09 Feb 22
Glenmark has secured accelerated approval from India’s drug regulator for manufacturing and marketing Nitric Oxide Nasal Spray (NONS)
09 Feb 22
Juvéderm Volbella XC is said to be the first and only dermal filler to receive FDA approval for…
08 Feb 22
Biogen will obtain exclusive global regulatory, manufacturing, and commercial rights to Xcimzane, along with the marketing authorisation